Suvarnaprashana - Concept or Factual Practice of Ayurveda

Authors

  • Rakesh Kumar Nagar Associate Professor, Department of Balroga, National Institute of Ayurveda (Deemed to be university), Jaipur Author
  • Nisha Ojha Associate Professor & H.O.D, Department of Balroga, National Institute of Ayurveda (Deemed to be university), Jaipur Author

DOI:

https://doi.org/10.48165/

Keywords:

Suvarnprashan, Suvarn Bhasma, Jatakarma, Lehana, Rasayana, immunological status, cognitive level

Abstract

In antiquity, gold was perceived as an important medication with various  favorable health effects. In an important book of Tao entitled Bauputz, the  author, Hung Kir (283–363 ad) stated: “ingest gold to live a gold-like  longevity”. These days, gold leaf, flake, or dust can be found adorning or  being added to a variety of dishes and drinks. However, its sole function is  that of a decorative accent. Gold, in all of its various medicinal forms, is  considered to be the most potent component of many distinct herbo-mineral  combinations in Ayurveda medicine. In pediatric populations, the usage of  gold is recommended right from birth, in conjunction with honey and ghee;  this process is known as Jatakarma in Ayurveda, while in the neonate and  above age group, to promote health, strength, longevity, etc., Lehana is  advised. Suvarnprashan is the name given to the practice of ingesting Suvarn  Bhasma together with a mixture of Rasyana and Balya medicines on a regular  basis for an extended period of time. Regular use of Suvarnprashan fosters  the child's overall growth. In addition to preventing infections, illnesses, and  allergic reactions, it has a good influence on the child's immune system.  Suvarnprashan may accelerate the development of the brain, the central  nervous system, and the generation of high-quality neurons, so that the future  cognitive abilities of the child will be exceptional. 

Downloads

Download data is not yet available.

References

Dutta P K, General and Inorganic chemistry, Vol II, 11th edition, Sarat Book House, Kolkata, 1996, 173

Gonda, The Functions and Significance of Gold in the Veda, Series: Orientalia Rheno-Traiectina, Volume: 37, https://brill.com/view/title/5913 (Retrieved on 2022.03.01) (Gold in the RV: 1-43-5; 3-34-9, 4-10-6, 17, 11)

Mishra S, Rasa Prakash Sudhakar, Siddhiprada Hindi Commentary, Reprint 2009, Chaukhambha Orientalia, Varanasi 4/4, page no. 66

Kulkarni DA, editor. New Delhi: Meharchand Lachhmandas Publications, 1998. Vagbhata, Rasaratna Samuchaya, Vol. 1, 5/1, 11, 18 pp. 13-6.

Shastri K. Rasatarangini Of Sadanandsharmavirchit. Panchadash Tarang Motilal Banarsidass Publishers Pvt. Ltd. New Delhi, 11th edition (Reprint),2000.pp.368

Singh N, Choudhary A. Suvarna Bhasma and Gold compounds: an innovation of pharmaceutical illumination of therapeutics. IJRAP 2012;3:1-9.

Sharma, P. V. (2018). Susruta Samhita with Dalhana’s commentary (Vol. 2). Chaukambha Vishva Bharti, Sharira Sthana, chapter 1, verse 32, Chaukambha Vishva Bharti, Sharira Sthana 2018.page no. 133.

Jadavji T, Charakasamhita of Agnivesh, Shareerasthana, chapter 8, verse 46, Chowkhambha Sanskrit Series, Varanasi, 2004 page no. 349.

Jadavji T, Susruthasamhita of Susruta, Shareerasthana, 10/13 & 19, Chaukhambha Orientalia Varanasi, 2002, p.388- 389.

Sastri HS, Paradakara, Ashtangahridaya of Vagbhata, Uttaras thana,1/8-9, 47&48, Chaukhambha Surbharati Prakashan, Varanasi, 2002, p.777- 778, 781

Tiwari, P. V. Kashyap Samhita. Chaukhambha Vishvabharti. Sutra Sthan, Lehadhyaya chapter 1, verse 25.2 – 28, Chaukhambha Vishvabharti 2018. page no. 7

Jadavji T, Susruthasamhita of Susruta, Shareerasthana, chapter 10, verse 13 & 19, Chaukhambha Orientalia Varanasi, 2002 page no. 388- 389.

Sastri HS, Paradakara, Ashtangahridaya of Vagbhata, Uttarasthana, chapter 1, verse 8-9, Chaukhambha Surbharati Prakashan, Varanasi, 2002 page no. 777- 778.

Sastri HS, Paradakara, Ashtangahridaya of Vagbhata, Chaukhambha Surbharati Prakashan, Varanasi, 2002, Uttarasthana, chapter 1, verse 47-49, page no. 781

Hari Sadasiva Sastri, Paradakara, Ashtangahridaya of Vagbhata, Uttarasthana, chapter 1, verse 8-9, Chaukhambha Surbharati Prakashan, Varanasi, 2002 page no. 777- 778.

Mishra BS, Bhavprakash with Vidyotini hindi commentry, 2nd part, Varanasi, Madhayam khanda, Balarogadhira 186- 187, Chaukhamba Sanskrit Sansthan, 2012. page no.812.

Jadavji T, Susruthasamhita of Susruta, Shareerasthana, chapter 10, verse 68, Chaukhambha Orientalia Varanasi, 2002 page no. 391- 392.

Tiwari, P. V. Kashyap Samhita.Sutra Sthan, Lehadhyaya chapter 1, page no. 3. Chaukhambha Vishvabharti 2018. 19. Tripathi B, Bhaishajya Ratnavali, Balroga Chikitsa, In: 71/5-6, 19, Varanasi: Chaukhamba Prakashan 2009.pg. 1073

Shastri K, editor 11th edition, Sadanand Sharma, Rastarangini, 15th Tarang, 2-3, 14, 27, New Delhi; Motilal Banarasidas; 2009 pg. 361-367

Sastri HS, Paradakara, Ashtangahridaya of Vagbhata, Uttarasthana, chapter 1, verse 9, 47–48- Chaukhambha Surbharati Prakashan, Varanasi, 2002 page no. 777- 778, 781.

Sharma, P. V. Susruta Samhita with Dalhana’s commentary (Vol. 2, Sharir Sthan, chaptr 10, verse 13, Chaukambha Vishva Bharti, 2018 page no. 227.

Anonymous, Part-1, Sec 18:20, 2nd edi. Delhi: The Controller of Publications, Govt. of India,2003, The Ayurvedic Formulary of India, pg. 247.

Shastri K, editor 11th edition, Sadanand Sharma, Rastarangini, 15th Tarang, 2-3, 14, 27, New Delhi; Motilal Banarasidas; 2009 pg. 361-367

Paul W, Sharma C P, Blood compatibility studies of suvarn bhasma, an Ayurvedic drug, Int. J Ayurveda Research. 2011, 2, 14-22 (PMC free article) (Pubmed)

Thakur K. Preparation and characterization of suvarnbharma parad merits. 2017;20(1):36–44.

Brown C, Bushell G R, whitehouse M, Agrawal Ds, Tupe S G, Paknikar K M et al , Nano gold pharmaceutics: Characterization of the gold in Swarna Bhasma, a microparticulate used in tradition Indian medicine, Gold Bull, 40 (2007)245-250

Jyothy KB, Sheshagiri S, Patel KS, Rajagopala S. A critical appraisal of suvarnprashan in children. 2014;35(4):361–5. 29. Kulkarni DA, editor. Vagbhata, Rasaratna Samuchaya, Vol. 1, 5/1, 11, New Delhi: Meharchand Lachhmandas Publications, 1998.pp. 13-6.

Shastri K., editor. 11 ^ (lh) ed. New Delhi: Motilal Banarasidas; 2009. Sadananda Sharma, Rasataranagini, 15 ^ (th) Taranga, 2-3,14,27; pp. 361-67.

Tiwari, P. V. Kashyap Samhita. Sutra sthan, Lehaadhyay Chaukhambha Vishvabharti. 2018.pp.1

Tiwari, P. V. Kashyap Samhita. Chaukhambha Vishvabharti. Sutra sthan, Lehaadhyay, Chaukhambha Vishvabharti. 2019. pp. 3-4.

Tiwari, P. V. Dalhana commentator. Sushruta Samhita, Sharira Sthana, Garbhinivyakarana Adhyaya, 10/68-70, reprint ed; Chaukhambha Orientalia: Varanasi; 2005. p. 395.

Gaikwad A. Jamnagar. India: Institute for Post Graduate Teaching and Research in Ayurveda, Gujarat Ayurved University; 2009-2011. A pharmaco-clinical study of effect of Madhu-Ghrita and Swarna-Vacha-Madhu-Ghrita on neonates. P.G. Dissertation work.

Bajaj S, Ahmad I, Raisuddin S, Vohora SB. Augmentation of non-specific immunity in mice by gold preparations used in traditional systems of medicine. Indian J Med Res. 2001; 113: 192–6. [PubMed]

P. Griem, K. Panthel, H. Kalbacher, et al. Alteration of a model antigen by Au(iii) leads to t cell sensitization to cryptic peptides, Eur J Immunol, 26 (1996), pp. 279-287

S. Han, K. Kim, H. Kim, et al. Auranofin inhibits overproduction of pro-inflammatory cytokines, cyclooxygenase expression and pge2 production in macrophages, Arch Pharm Res, 31 (2008), pp. 67-74

Khedekar S, Immunomodulatory Activity of Swarna Prashana in Charle’s Foster Albino Rats , J Ayu Med Sci | 2016 | Vol 1 | Issue 2 (Oct – Dec)

Ahir J, a control clinical study of suvarna prashana in recurrent upper respiratory tract infection in children, Paripex - Indian Journal Of Research, Volume-7 | Issue-12 | December-2018 | PRINT ISSN No 2250-1991.

Warad Vijayanand B et.al. Preparation and screening of Swarnaprashana for nootropic activity, International Journal of Nutrition, Pharmacology, Neurological Diseases , Vol. 4,4(2014):170-178

Jyothy K et al. “Immunomodulatory activity of Swarna Prashana (oral administration of gold as electuary) in infants - A randomized controlled clinical trial.” Ayu vol. 40,4 (2019): 230-236. doi:10.4103/ayu.AYU_33_19

Bajaj S, Ahmad I, Raisuddin S, Vohora SB. Augmentation of non-specific immunity in mice by gold preparations used in traditional systems of medicine. Indian J Med Res. 2001 May: 113: 192-6)

Bajaj S, Ahmad I, Fatima M, Raisuddin S, Vohora SB. Immunomodulatory activity of a unani gold preparation used in Indain system of medicine. Immunopharmacol Immunotoxicol. 1999 Feb;21(1):151-61)

Gaikwad A S, Patel K S, Rajagopala S, ‘A Pharmaco Clinical study of the effect of Madhu-Ghrita and Swarna Vacha-Madhu-Ghrita on Neonates’2011

Measel JW. Effect of gold on the immune response of mice, Infection and immunity, 1975 ; February 11 (2): 350- 354.

Sharma V. Toxicity study of Swarna bindu prashan in albino rats. Belgaum, India: K.L.E.U.'s Shri B.M. Kankanawadi Ayurved Mahavidyalaya; 2010-2012.

Batheja P, Thakur R, Michniak B. Basic biopharmaceutics of buccal and sublingual absorption. In: Touitou E, Barry BW, editors. In Enhancement in Drug Delivery. New York: CRC Press; 2007.

Hillyer J F, Albrecht RM. Gastrointestinal persorption and tissue distribution of differently sized colloidal gold nanoparticles. J Pharm Sci. 2001 Dec ;90(12): 1927- 36

Gilman G, J. Hardman, L. Limbird, Goodman & Gilman’s The Pharmacological Basis of Therapeutics (McGraw Hill, ed. 9, 1996).

R. C. Elder, M. K. Eidsness, Synchrotron X-ray studies of metal-based drugs and metabolites. Chem. Rev. 87, 1027– 1046 (1987).

E. McQueen, P. Dykes, Transport of gold in the body. Ann. Rheumatic Dis. 28, 437 (1969).

J. Linck, “Hépatite aurique cholestatique persistante: à propos d’une observation syndrome d’hypersensibilité aux sels d’or et relation avec le système HLA” PhD thesis, Université Henri Poincaré, Nancy, France (2005).

F. Ghadially, The aurosome. J. Rheumatol. 5, 45–50 (1979).

Takahashi, P. Griem, C. Goebel, J. Gonzalez, E. Gleichmann, The antirheumatic drug gold, a coin with two faces: Au (i) and Au (iii). Desired and undesired effects on the immune system. Met. Base. Drugs 1, 483–496 (1994).

https://www.macrotrends.net/countries/IND/india/infant mortality-rate (retrieved on 2022.03.21)

Tiwari P. V. (2018). Kashyap Samhita. Chaukhambha Vishvabharti. Sutra sthan, page 9

Sinha N., & Ojha, N. (2021). Study of pattern of morbidity in children under 5 years and effect of Swarnaprashan on morbidity status. Journal of Ayurveda, 15(3), 170-170.

Gulhane et al. Scientific View towards Suvarnaprashana in Alternative Medicines Int J Ayu Pharm Chem. 2015 Vol. 3 Issue 3,128-137.

Downloads

Published

2022-05-31

Issue

Vol. 5 No. 5 (2022): International Research Journal of Ayurveda And Yoga ( May) 2022

Section

Review Article

How to Cite

Nagar, R. K., & Ojha, N. (2022). Suvarnaprashana - Concept or Factual Practice of Ayurveda . International Research Journal of Ayurveda & Yoga, 5(5), 185-192. https://doi.org/10.48165/
Crossref
Scopus
Google Scholar
Europe PMC